Company: PFSA
Filing Date: 2025-02-19
Form Type: 8-K
Source: 0001213900-25-014987
Chunk: 4

Company: Profusa, Inc.
Filing Date: 2025-02-19
Form: 8-K
Item: Item 1.01
Chunk 4
---
 Profusa’s business plans including its plans to expand, the
sources and uses of cash from the proposed transaction, the anticipated enterprise value
of the combined company following the consummation of the proposed transaction, any benefits
of Profusa’s partnerships, strategies or plans as they relate to the proposed transaction,
anticipated benefits of the proposed transaction and expectations related to the terms and
timing of the proposed transaction are also forward-looking statements. These statements
involve risks, uncertainties and other factors that may cause actual results, levels of activity,
performance or achievements to be materially different from those expressed or implied by
these forward-looking statements. Although each of NorthView and Profusa believes that it
has a reasonable basis for each forward-looking statement contained in this communication,
each of NorthView and Profusa caution you that these statements are based on a combination
of facts and factors currently known and projections of the future, which are inherently
uncertain. In addition, there will be risks and uncertainties described in the proxy statement/prospectus
on Form S-4 relating to the proposed transaction, which is expected to be filed by NorthView
with the SEC and other documents filed by NorthView or Profusa from time to time with the
SEC. These filings may identify and address other important risks and uncertainties that
could cause actual events and results to differ materially from those contained in the forward-looking
statements. Neither NorthView nor Profusa can assure you that the forward-looking statements
in this communication will prove to be accurate. These forward-looking statements are subject
to a number of risks and uncertainties, including, among others, the ability to complete
the business combination due to the failure to obtain approval from NorthView’s stockholders
or satisfy other closing conditions in the Merger Agreement, the occurrence of any event
that could give rise to the termination of the Merger Agreement, the ability to recognize
the anticipated benefits of the business combination, the amount of redemption requests made
by NorthView’s public stockholders, costs related to the transaction the risk that
the transaction disrupts current plans and operations as a result of the announcement and
consummation of the transaction, the outcome of any potential litigation, government or regulatory
proceedings and other risks and uncertainties, including those to be included under the heading
“ Risk Factors” in the final prospectus for NorthView’s initial public offering
filed with the SEC on December 22, 2021 and in its subsequent annual and quarterly reports
on Forms 10-K